Post-HSCT management of paediatric patients with ALL

Share :
Published: 10 Nov 2021
Views: 283
Prof Christina Peters - St. Anna Children's Hospital, Vienna Austria

Prof Christina Peters speaks to ecancer about her presentation at ALL Assembly 2021 on post-HSCT (haematopoietic stem cell transplantation) management of paediatric patients with acute lymphoblastic leukaemia (ALL).

She explains that the session focused on how to prevent relapse in patients with high-risk features, going into detail on how patients are monitored and managed post-transplant to minimise chances of relapse.

ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.